Biocytogen
ID: 5330791Biocytogen is a biotechnology company headquartered in Beijing developing antibody drug discovery solutions based on gene editing and animal model studies.
4
Funding Rounds
$284.4m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Yu**** Sh** | - | - |
Funding
Funding series
Funding Series Analysis
The company Biocytogen has raised a total of $142.4m in funding over 4 rounds.
Key Insights:
- Biocytogen Series D round, August 2019: $79m
- Beijing Biocytogen Co., Ltd. Series C round, April 10, 2018: $63.4m
- Biocytogen Series D round(extension), September 2020: $142m
Industries
Biocytogen is active in the following industries: